Interview 10 Jul 2017 Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease I spoke with Marc Martinell, CEO of Minoryx, to learn first-hand how his company in Barcelona is bringing new hope for patients suffering from rare diseases. Having previously worked in Crystax Pharmaceuticals and Oryzon Genomics, Marc Martinell is now CEO of one of Spain’s most successful biotechs. Minoryx Therapeutics is developing what could be the first […] July 10, 2017 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jul 2017 Memories Encoded in DNA and Biological Reliques Margherita Pevere is an artist that uses living organisms to explore our relationship with nature and technology, and our obsession with preserving information. Margherita Pevere is an artist fascinated by the connection between humans and nature, and how the pervasive introduction of technology into all aspects of our lives is affecting this relationship. Her work puts living […] July 8, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jul 2017 French Mobile Diabetes Firm gets €17.5M to Build an Artificial Pancreas Cellnovo has launched a capital increase from top European investors to boost its mobile system for diabetes and complete the development of a fully automated artificial pancreas. Cellnovo is a French medtech company with an all-in-one system to manage diabetes in the market. The company has now announced a capital raise of €17.5M to boost […] July 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 7 Jul 2017 A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections This week we’re traveling to Bergen, a beautiful coastal city in Norway surrounded by seven mountains, where a biotech called Cytovation is developing a brand new treatment for benign tumors caused by the human papillomavirus. Mission: Cytovation is developing what could be the first prescription treatment for cutaneous warts, which are a form of […] July 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 6 Jul 2017 Watch Europe’s Rising Biotech Startups Battle it out at Refresh After the early stage startups gave it all on stage, it was the turn of the more advanced biotechs to fight each other at Labiotech Refresh 2017. The first contestant was Beroceutica, a startup from Germany that uses artificial intelligence to look for biomarkers that allow better patient stratification in clinical trials. The goal is to increase the success […] July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 6 Jul 2017 Lab-Grown Bile Ducts Can Replace Liver Transplant in Mice A new study describes a method that could be used to regenerate bile ducts in children with biliary atresia instead of waiting for a liver transplant. Researchers at the University of Cambridge might have found an alternative to transplant for children with liver disease. Their results, published today in Nature Medicine, reveal that primitive bile ducts grown […] July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jul 2017 Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II Prothena and Roche are advancing their Parkinson’s antibody to Phase II, triggering a new milestone payment from what is proving a lucrative deal for Prothena. Prothena, the largest biopharma in Ireland, and its partner Roche have announced the first patient has been enrolled in a Phase II trial testing an antibody treatment for Parkinson’s. Reaching […] July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2017 Results are in from the First Human Trial of an Universal Cancer Vaccine BioNTech has published results from the first clinical trial for an mRNA-based individualized vaccine with the potential to target all cancer types. Published in Nature, the results from the first trial in humans with a personalized mRNA cancer vaccine hint that BioNTech is on a promising track towards the development of a universal cancer vaccine. All […] July 5, 2017 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2017 Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of indications in filgotinib’s clinical pipeline. Galapagos and Gilead clearly have big expectations for filgotinib. The small molecule is already in Phase III for rheumatoid arthritis, Crohn’s disease and ulcerative colitis. The team is now launching a new Phase II trial in […] July 5, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jul 2017 British Liquid Biopsy for Ovarian Cancer Outperforms the Gold Standard The British company Angle has announced results from a large-scale trial that seem to indicate its liquid biopsy technology could surpass the gold standard in ovarian cancer diagnosis. Angle, in the UK, is developing liquid biopsy tests to replace biopsies in the diagnosis of cancer. The company has announced results from a 400-patient trial in […] July 4, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jul 2017 Quantum Worms from London win the Biodesign Challenge 2017 A team of students from Central Saint Martins, London, has won this year’s biodesign challenge with a project in which worms turn into tech factories. Every year, teams working at the intersection of biology and design compete to win the Biodesign Challenge held at the famous New York City’s Museum of Modern Art (MoMA). This year’s edition […] July 1, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2017 Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy based on off-the-shelf mRNA technology. eTheRNA is one of the few companies working in mRNA therapies that are running clinical trials. The Belgian biotech has announced the start of a Phase Ib trial with its candidate TriMix-MEL, also called ECI-006, in patients […] June 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email